Evidence map›Paper›PMID 23860623›Full record

ArticleEndocrine2014

Expression of hedgehog signalling pathway in anaplastic thyroid cancer.

Ulrike Hinterseher, Annette Wunderlich, Silvia Roth, Annette Ramaswamy, Detlef K Bartsch, Stefan Hauptmann, Brandon H Greene, Volker Fendrich, Sebastian Hoffmann

Abstract read
PubMed Publisher
In one paragraph

Article in Endocrine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Sonic Hedgehog Signaling in Thyroid Cancer.Frontiers in endocrinology · 2017
    Review
  8. The sonic hedgehog signaling pathway contributes to the development of salivary gland neoplasms regardless of perineural infiltration.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Review
  15. Aberrant sonic hedgehog signaling pathway and STAT3 activation in papillary thyroid cancer.International journal of clinical and experimental medicine · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Ulrike HinterseherDepartment of Visceral, Thoracic- and Vascular Surgery, University Hospital Marburg, Baldingerstrasse, 35043, Marburg, Germany.
Annette Wunderlich
Silvia Roth
Annette Ramaswamy
Detlef K Bartsch
Stefan Hauptmann
Brandon H Greene
Volker Fendrich
Sebastian Hoffmann
Philipps University of Marburg · DEUniversidad CES · COUniversity Hospital in Halle · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this work is to study the activation of the hedgehog signalling pathway is associated with tumour progression in various types of cancer, hence the development of specific antagonists raises hope for new therapeutic strategies. Therefore, the expression of hedgehog pathway components in anaplastic thyroid cancer (ATC) and effects of the hedgehog inhibitor Cyclopamine on ATC cells were investigated in this study. Expression of the ligand Sonic Hedgehog (SHh), the transmembrane protein Smoothened (Smo), the receptor Patched (Ptc) and the target gene Gli-1 was evaluated in two ATC cell lines (Hth 74, C643) by RT-PCR and in tumour specimens by immunohistochemistry. The corresponding gene products were examined by western blotting analysis. After treatment with different concentrations of Cyclopamine the time-dependent course of cell viability in ATC cell lines was evaluated by MTT assay. SHh, Smo, Ptc and Gli were clearly expressed on mRNA and protein levels in both cell lines and in tumour samples (41 %SHh, 65 %Smo, 65 %Ptc and 65 %Gli). Treatment with Cyclopamine showed a time- and dose-dependent inhibition of cell numbers with IC50 values between 1 and 4 μM in both cell lines, comparable to other types of cancer. In conclusion, we believe that the hedgehog pathway is expressed in anaplastic thyroid carcinoma specimens and proliferation of ATC cell lines can be influenced by the Hh inhibitor Cyclopamine. Aberrant activation of this pathway might be involved in the aggressive biology of anaplastic cancer and further evaluation regarding a possible clinical impact of pathway inhibition is warranted.

Indexed as

Biomarkers, TumorCell Line, TumorHedgehog ProteinsHumansInhibitory Concentration 50Patched ReceptorsReceptors, Cell SurfaceReceptors, G-Protein-CoupledRNA, MessengerSignal TransductionSmoothened ReceptorThyroid Carcinoma, AnaplasticTranscription FactorsVeratrum AlkaloidsZinc Finger Protein GLI1Biomarkers, TumorcyclopamineGLI1 protein, humanHedgehog ProteinsPatched ReceptorsReceptors, Cell SurfaceReceptors, G-Protein-CoupledRNA, MessengerSHH protein, humanSmoothened ReceptorSMO protein, humanTranscription FactorsVeratrum AlkaloidsZinc Finger Protein GLI1

Identifiers

PMID23860623
OpenAlexW2143434569

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.